Back to Results

Arkema SA ADR (ARKAY)

Arkema S.A. ADR is a depositary receipt linked to the ordinary shares of Arkema S.A., a French specialty materials company headquartered in Puteaux, France. The underlying group was incorporated in 2003 and operates internationally across Europe, North America, and parts of Asia. Its business is organized into three main segments: Adhesive Solutions, Advanced Materials, and Coating Solutions, along with Intermediates.

Arkema develops materials and chemical products used in construction, renovation, packaging, automotive, textiles, electronics, water treatment, refrigeration, and other industrial applications. Its portfolio includes adhesives, high-performance polymers, additives, coating resins, decorative and industrial coatings, fluorogases, and industrial intermediates, as well as solutions related to lightweighting, new energy, recycling, and bio-based materials.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-ARKA.Y
$71.12
14.5% Upside
Fair
$86.50
39.2% Upside
Undervalued
Fair
—
—
3.52
5.7%
July 30, 2026
241.2x
0.6x
0.5x
4.684 B
7.892 B
49.9%
75.3%
8.0
722.0%
2,265.9%
Send a message
Valuation • Fair Value

Arkema SA ADR (OTC-ARKA.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for Arkema SA ADR (OTC-ARKA.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$71.12

Estimated upside of 14.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$77.66

Discounted cash flow valuation reference.

Ben Graham Formula Value

$2.85

Classic Ben Graham valuation formula reference.

DDM Fair Value

$69.62

Dividend discount model valuation reference.

EPV Fair Value

$58.47

Earnings power value estimate.

Comps Fair Value

$66.94

Comparable-company valuation reference.

Analyst Price Target

$86.50

Analysts imply upside of 39.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Arkema SA ADR (OTC-ARKA.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Arkema SA ADR (OTC-ARKA.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

10.251 B

Current operating scale indicator.

Revenue Forecast

10.403 B

Forward revenue estimate.

EBITDA

1.279 B

Current operating profitability reference.

EBITDA Forecast

1.447 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Arkema SA ADR (OTC-ARKA.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Arkema SA ADR (OTC-ARKA.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.89

No elevated caution signal from this screen.

Altman Z-Score

8.0

Relatively strong balance-sheet zone.

FCF / Net Income

2,265.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Arkema SA ADR (OTC-ARKA.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Arkema SA ADR (OTC-ARKA.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

5.7%

Income yield reference.

Upcoming Dividend

3.52

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

722.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Arkema SA ADR (OTC-ARKA.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Arkema SA ADR (OTC-ARKA.Y) Stock Forecast & Technical Outlook

Review Arkema SA ADR (OTC-ARKA.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Arkema SA ADR (OTC-ARKA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Arkema SA ADR (OTC-ARKA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Arkema SA ADR (OTC-ARKA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Arkema SA ADR (OTC-ARKA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Arkema SA ADR (OTC-ARKA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Arkema SA ADR (OTC-ARKA.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Arkema SA ADR (OTC-ARKA.Y) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Arkema SA ADR (OTC-ARKA.Y) Stock FAQ

Quick answers about Arkema SA ADR (OTC-ARKA.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$71.12
Estimated upside 14.5%
Valuation Rating
Undervalued
Estimated upside of 14.5%
Analyst Target
$86.50
Implied upside 39.2%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Arkema SA ADR (OTC-ARKA.Y) is $71.12. This implies an estimated upside of 14.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 14.5% versus the current market price.

The available analyst price target for Arkema SA ADR (OTC-ARKA.Y) is $86.50. The analyst target implies estimated upside of 39.2%.

The current financial health read for Arkema SA ADR (OTC-ARKA.Y) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Arkema SA ADR (OTC-ARKA.Y) is July 30, 2026.

Based on the current data, dividend yield is 5.7%, upcoming dividend amount is 3.52.

The current P/E ratio listed for Arkema SA ADR (OTC-ARKA.Y) is 241.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Arkema SA ADR is 4.684 B.

The current enterprise value listed for Arkema SA ADR is 7.892 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Arkema SA ADR is OTC-ARKA.Y, and the stock is listed on OTC Markets.

Arkema SA ADR (OTC-ARKA.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Arkema SA ADR is 49.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Arkema SA ADR is 75.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Chemicals Stocks on OTC Markets View more

Air Liquide SA ADR (AIQUY) Air Liquide SA ADR (AIQUY)
Shin-Etsu Chemical Co Ltd ADR (SHECY) Shin-Etsu Chemical Co Ltd ADR (SHECY)
BASF SE ADR (BASFY) BASF SE ADR (BASFY)
BASF SE NA O.N. (BFFAF) BASF SE NA O.N. (BFFAF)
Givaudan SA ADR (GVDNY) Givaudan SA ADR (GVDNY)
Sika AG ADR (SXYAY) Sika AG ADR (SXYAY)
Novozymes AS (NVZMF) Novozymes AS (NVZMF)
Novozymes AS DRC (NVZMY) Novozymes AS DRC (NVZMY)
Resonac Holdings Corp DRC (SHWDY) Resonac Holdings Corp DRC (SHWDY)
Asahi Kaisei Corp (AHKSY) Asahi Kaisei Corp (AHKSY)
Covestro ADR (COVTY) Covestro ADR (COVTY)
Symrise Ag PK (SYIEY) Symrise Ag PK (SYIEY)
Ganfeng Lithium Co Ltd (GNENF) Ganfeng Lithium Co Ltd (GNENF)
Nitto Denko Corp (NDEKY) Nitto Denko Corp (NDEKY)
Yara International ASA (YARIY) Yara International ASA (YARIY)
Akzo Nobel NV ADR (AKZOY) Akzo Nobel NV ADR (AKZOY)
Chandra Asri Petrochemical Tbk PT ADR (PTCAY) Chandra Asri Petrochemical Tbk PT ADR (PTCAY)
Toray Industries Inc ADR (TRYIY) Toray Industries Inc ADR (TRYIY)
Mitsubishi Chemical Holdings Corp ADR (MTLHY) Mitsubishi Chemical Holdings Corp ADR (MTLHY)
Orica Ltd ADR (OCLDY) Orica Ltd ADR (OCLDY)
Nissan Chemical Industries Ltd ADR (NNCHY) Nissan Chemical Industries Ltd ADR (NNCHY)
Croda International PLC ADR (COIHY) Croda International PLC ADR (COIHY)
Sumitomo Chemical Co Ltd ADR (SOMMY) Sumitomo Chemical Co Ltd ADR (SOMMY)
Fuchs Se ADR (FUPBY) Fuchs Se ADR (FUPBY)